首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model.
【24h】

Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model.

机译:左炔诺孕酮和米非司酮对三维人子宫内膜细胞培养模型中子宫内膜容受性标志物的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To investigate the effect of levonorgestrel and mifepristone on the expression of endometrial receptivity markers in a three-dimensional endometrial construct. DESIGN: In vitro study. SETTING: University hospital and research laboratory. PATIENT(S): Twelve fertile donors. INTERVENTION(S): Timed endometrial biopsy. MAIN OUTCOME MEASURE(S): Examine the effect of levonorgestrel along with another well-studied fertility-regulating drug, mifepristone, on the expression of endometrial receptivity factors in a three-dimensional stromal and epithelial cell coculture model by immunohistochemistry. RESULT(S): Both epithelial and stromal cells of in vitro endometrial construct showed the presence of estrogen receptor-alpha, estrogen receptor-beta, progesterone receptors-(A+B), vascular endothelial growth factor, leukemia inhibitory factor, interleukin-1 beta, and cyclooxygenase-2, whereas the expression of progesterone receptor-B (AR), integrin alpha(V)beta(3,) and MUC1 were confined to epithelial cells. Mifepristone up-regulated expression of epithelial estrogen receptor-beta and progesterone receptor-B and down-regulated stromal vascular endothelial growth factor and surface molecules MUC1 and integrin alpha(V)beta(3) as observed in vivo. Levonorgestrel had no effect on the expression of endometrial receptivity markers studied. CONCLUSION(S): This in vitro model expresses progesterone-regulated endometrial receptivity factors seen in the physiologic condition. Treatment with levonorgestrel did not affect the expression of these endometrial receptivity markers in contrast to mifepristone. This in vitro model holds the potential to study endometrial receptivity, the embryo-endometrial interaction, and develop new agents for fertility control.
机译:目的:探讨左炔诺孕酮和米非司酮对三维子宫内膜结构中子宫内膜容受性标志物表达的影响。设计:体外研究。地点:大学医院和研究实验室。患者:十二位可育的供体。干预措施:定时子宫内膜活检。主要观察指标:通过免疫组织化学检查左炔诺孕酮和另一种经过充分研究的生育力调节药物米非司酮对子宫内膜接受因子在三维基质和上皮细胞共培养模型中表达的影响。结果:体外子宫内膜构建物的上皮和基质细胞均显示雌激素受体α,雌激素受体β,孕激素受体(A + B),血管内皮生长因子,白血病抑制因子,白介素-1 β和环氧合酶2,而孕激素受体B(AR),整联蛋白alpha(V)beta(3)和MUC1的表达仅限于上皮细胞。米非司酮在体内观察到上调上皮雌激素受体β和孕激素受体B的表达,并下调基质血管内皮生长因子和表面分子MUC1和整联蛋白α(V)β(3)的表达。左炔诺孕酮对所研究的子宫内膜容受性标志物的表达没有影响。结论:该体外模型表达在生理条件下观察到的孕激素调节的子宫内膜容受因子。与米非司酮相比,左炔诺孕酮治疗不影响这些子宫内膜容受性标志物的表达。这种体外模型具有研究子宫内膜的接受性,胚胎与子宫内膜的相互作用以及开发用于控制生育力的新药物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号